Technical Specifications

• CAS Number: 170851-70-4
  
• Molecular Formula: C₃₈H₄₉N₉O₅
  
• Molecular Weight: 711.9 g/mol
  
• PubChem ID: 9831659
  
• Purity: ≥99% (HPLC tested)
  
• Form: Lyophilized powder
• Synthesis Method: Solid-phase peptide synthesis
  

Analytical & Testing

Each batch of Ipamorelin undergoes high-performance liquid chromatography (HPLC) and mass spectrometry (MS) analysis to verify purity, identity, and analytical consistency. A corresponding Certificate of Analysis (COA) is available for each batch.

Handling & Storage

This compound should be handled by qualified professionals in controlled laboratory environments. Proper storage conditions should be maintained to preserve compound stability and structural integrity.

Research Context

In preclinical and laboratory research models, Ipamorelin has been examined across endocrine, metabolic, and cellular systems. Research focus includes:

• Ghrelin receptor (GHS-R1a) signaling pathways
• Growth hormone–related activity models
• Hormonal pathway interactions
• Cellular signaling mechanisms

These observations are limited to controlled experimental environments and support ongoing laboratory investigations.

Research Application Scope

Ipamorelin continues to be evaluated for its relevance in experimental biology, particularly within studies involving endocrine signaling, receptor-level interactions, and cellular pathway analysis.

Use Statement

For laboratory research use only. Intended strictly for in vitro research applications.

Disclaimer

All products currently listed on this site are for research purposes ONLY.